// App-Quantinova.ai

: Predicting institutionalization and mortality across the spectrum of Alzheimer’s Disease

Researchers

Presenter

  • Arenda Mank

Principal Investigators

  • Ingrid S. van Maurik

  • Els D. Bakker

  • Charlotte E. Teunissen

  • Frederik Barkhof

  • Philip Scheltens

  • Johannes Berkhof

  • Wiesje M. van der Flier

Medical Centers

  • Department of Anatomy and Neurosciences, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC

  • Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Epidemiology and Data Science

  • VU University Medical Center, Alzheimer center VUmc, Neurocampus

  • Institutes of Neurology & Healthcare Engineering, University College London

  • University Medical Center Utrecht,

  • VU University Medical Center, Alzheimer Center, Amsterdam Neuroscience

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • White matter hyperintensities

  • Mild cognitive impairment

  • Alzheimer's disease

  • Dementia

Biomarkers

  • Apolipoprotein E

  • Amyloid beta 42

  • Stearoyl-CoA desaturase

  • Cerebrospinal fluid

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved